Invention Application
- Patent Title: TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES
-
Application No.: PCT/US2019/068185Application Date: 2019-12-20
-
Publication No.: WO2020132658A2Publication Date: 2020-06-25
- Inventor: HAN, Amy , KELLY, Marcus , OLSON, William
- Applicant: REGENERON PHARMACEUTICALS, INC.
- Applicant Address: 777 Old Saw Mill River Road Tarrytown, New York 10591-6707 US
- Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee Address: 777 Old Saw Mill River Road Tarrytown, New York 10591-6707 US
- Agency: NOSON, Kevin et al.
- Priority: US62/784,325 20181221
- Main IPC: C07K5/02
- IPC: C07K5/02 ; C07K5/078 ; A61K47/68 ; A61P35/00
Abstract:
Provided herein are compounds, compositions, and methods for the treatment of diseases and disorders associated with cancer, including tubulysins and protein ( e.g. , antibody) drug conjugates thereof.
Public/Granted literature
- WO2020132658A3 TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES Public/Granted day:2020-06-25
Information query
